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High glucose level and angiotensin 
II type 1 receptor stimulation 
synergistically amplify oxidative 
stress in renal mesangial cells
tetsuya Akaishi  1, Michiaki Abe  1,2, Hiroshi okuda1, Kota Ishizawa1, takaaki Abe  2, 
tadashi Ishii1 & sadayoshi Ito2
Oxidative stress in renal mesangial cell causes diabetic glomerular changes. High glucose levels and 
angiotensin II (Ang II) are known to stimulate superoxide production in renal mesangial cells. However, 
it has been unclear whether Ang II stimulation and pre-conditioning with high glucose affects the 
same pathway of superoxide production in renal mesangial cells or not. In this study, we examined 
the levels of oxidative stress under Ang II stimulation in renal mesangial cells preincubated for six 
hours at various glucose levels. Intracellular levels of reactive oxidative species (ROS) were measured 
using dihydroethidium or 5′,6′-chloromethyl- 2′,7′ dichlorodihydro-fluorescein diacetate, which 
facilitates the detection of intracellular ROS under real-time fluorescent microscope. Ang II-induced 
elevated intracellular ROS levels were detected only when the cells were pre-incubated with high 
levels of glucose (13.5 mM, 27.8 mM), but was not detected under normal glucose condition (5.5 mM). 
Production of Ang II-induced intracellular ROS was higher under pre-treatment with 27.8 mM glucose 
compared to pretreatment with 13.5 mM glucose level. This ROS production in mesangial cells was 
induced within several minutes of the initiation of Ang II stimulation under high glucose levels. The 
production of intracellular ROS was significantly reduced in the presence of angiotensin II type1-
receptor (AT1R) antagonist, whereas it was augmented in the presence of angiotensin II type2-receptor 
antagonist. In conclusion, Ang II-induced oxidative stress was augmented by high glucose levels and 
ROS levels were further alleviated in the presence of AT1R antagonists.
Renal glomerular changes in diabetic patients are recognized as mesangial expansion and fusion of foot processes 
on podocytes1,2. These glomerular pathological changes are triggered by oxidative stress and one of the generator 
of such changes is mesangial cell (MC)3,4. MCs are known to produce extracellular matrix as supportive tissue 
and to maintain glomerulocapillary structure by contracting, or to act as immune cells like phagocytes5–7. Since 
MCs in renal glomeruli can contract and hold the capillaries together at the stalk, damages in them could result in 
mesangial expansion. Previous studies on the pathophysiological mechanism in diabetic nephropathy reported 
that very high concentration of glucose (i.e. ~25–30 mM), which is equivalent to about 450–540 mg/dL serum 
glucose level, increases the oxidative stress via increase in reactive oxygen species (ROS) in MCs8,9. However, 
whether such intracellular ROS production also occurs at lower levels of glucose (10–15 mM; 180–270 mg/dL 
serum glucose level) is still inconclusive. Since microalbuminuria, which is associated with diabetic microvascu-
lar complication, can be observed in the early stage of impaired glucose tolerance, there is a possibility that such 
ROS production also occurs in this condition under mildly elevated glucose levels10. If such a speculation could 
be validated, it would strongly suggest that hyper-activated ROS production in renal mesangial cells are associ-
ated with the pathogenesis of diabetic glomerular injury from the early stages.
In addition to the high glucose levels, angiotensin II (Ang II) stimulation has been also reported to pro-
mote ROS production in MCs11–13. Only a few studies that evaluated the ROS production in MCs under differ-
ent glucose levels and Ang II stimulation conditions, especially under mild glucose levels have been conducted. 
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Moreover, there has been no study on the evaluation of ROS production in MCs under various glucose levels and 
Ang II stimulations given at different times.
To verify that ROS production in MCs, stimulated by elevated glucose levels and Ang II, is one of the essential 
pathophysiological mechanisms in diabetic nephropathy, we exposed the cultured MCs separately to mild glucose 
levels and Ang II stimulations at different timings and observed the ROS production in them over time. In this 
study, we measured the production of ROS in MCs over time after pre-incubating for six hours under various 
glucose levels (5.5, 13.5, and 27.5 mM) with or without Ang II stimulation. Besides, to investigate the synergistic 
negative effect of glucose and Ang II, Ang II was administered at different timings in the presence of glucose.
Materials and Methods
Reagents. Dihydroethidium (DHE) and 5′,6′-chloromethyl-2′,7′ dichlorodihydro-fluorescein diacetate 
(CM-H2DCFDA) were purchased from Molecular Probes Inc. (Eugene, OR). Both reagents were dissolved with 
DMSO and diluted for daily use. Modified Hanks’ balanced salt solution (HBSS) and fetal calf serum (FCS) were 
purchased from Invitrogen (Carlsbad, CA). D-glucose (glucose), L-glucose, Ang II, HEPES, L-arginine, Tiron, 
PD123319 (angiotensin II type 2-receptor antagonist), and polyethylene glycol (PEG)-catalase were purchased 
from Sigma (St. Louis, MO), while RNH-6270 (angiotensin type1-receptor antagonist) was purchased from 
Sankyo Co. (Tokyo, Japan).
Mesangial cell cultures. The human mesangial cells (MCs) (Cambrex, Walkersville, MD) were spread and 
cultured on 15 mm-round cover glasses in MsBN medium (Cambrex, Walkersville, MD) containing 5% v/v FCS 
and 0.1% v/v gentamicin sulfate/amphotericin-B under an atmosphere of 95% O2/5% CO2 at 37 °C. The cells were 
used from 6th to 10th passage.
Real-time fluorescence imaging of cells. Fluorescence measurements were obtained using IX71 inverted 
microscope (Olympus, Tokyo, Japan) attached with a 60× (numerical aperture 0.9) water-immersion objective 
lens as previously reported14. The signal was detected by a cool CCD video camera Ixon (Andor Co., Tokyo, 
Japan) coupled to Lambda-10.2 (Sutter Instruments, CA), and excitation was provided by Sutter DG-4 and 175-W 
Xenon-Arc lamp (Sutter Instruments, Navato, CA). For the experiments, cover slips were placed in an imag-
ing chamber (RC-42LP and RC-43C; Warner Instruments, Hamden, CT) mounted on the stage of the inverted 
microscope and maintained at 37 °C with TC-344B thermo-warmer for chamber and TA-29 thermo-warmer 
for perfusate (Warner Instruments, Hamden, CT). The changes in fluorescence intensity were quantified using 
MetaFluor imaging software (Universal Imaging Co., Ypsilanti, MI) for each experiment. To exclude the possi-
bility of selection bias of the measured MCs, the fluorescence intensity of all living mesangial cells in each cover 
glass was measured.
Measurement of oxidative stress in mesangial cells. Protocol 1 (evaluation of O.2− production in MCs 
under various conditions). MCs cultured till ~75–90% confluence on 15 mm-round cover glasses were incu-
bated in the culture media containing 5.5 mM (100 mg/dL) or 13.5 mM (240 mg/dL) glucose with or without 
10–7 M Ang II for 6 hours. The cover glass was set on the chamber of the microscope and cells were washed with 
HBSS containing 20 mM HEPES, 5.5 mM glucose, and 100 μM L-arginine (pH7.4). The buffer was subsequently 
exchanged with assay buffer containing 5 µM of DHE. DHE-penetrated cell membrane and intracellular DHE 
is oxidized by O.2− to form ethidium (Eth), which integrates into DNA. Intracellular Eth was excited at 480 nm 
wavelength and red fluorescent signal was detected through emission filter of 605 nm wavelength, as shown in 
Fig. 114–16. As dying cells were detached from the bottom, imaging signal of Eth was collected after every 10 s from 
each living cell attached to the bottom of the cover glass. For each condition, a total of five cover glasses were 
prepared, each of which contained about 10–15 live MCs on the bottom. Fluorescent signal from each of all living 
MCs under each pre-condition and timing was quantified.
Protocol 2 (evaluation of acute response of H2O2 against Ang II stimulation in MCs). MCs were incubated in 
culture media containing 5.5, 13.5, or 27.8 mM glucose for 6 hours. The cells were next washed with vehicle 
buffer containing 300 nM CM-H2DCFDA at a continuous flow rate of 1 mL/min. CM-H2DCFDA is converted 
to H2DCF by cellular esterase and trapped in the cell. Then, intracellular H2DCF is oxidized by ROS and gets 
converted into fluorescent DCF17,18. For stimulation of MCs, the assay buffer was exchanged with stimulation 
buffer containing 10−7 M of Ang II. The active form of DCF was excited at 480 nm wavelength and the signal was 
detected through emission filter of 535 nm wavelength. The imaging signals of cells attached on cover glass were 
collected after every 10 s.
Statistical analysis. In protocol 1, the slopes of the Eth response were calculated from the final 300 s of 
experimental period after the control equilibration. In protocol 2, the slopes of the DCF were calculated from the 
final 150 s of vehicle and Ang II period. All data were presented as mean ± standard error (SE). The significance 
of slope in the responses between vehicle and compounds was performed using unpaired Student’s t-test. The 
significance of change in the slope of each response curve from the control period (0–160 s) to the experimental 
period (180–340 s) was evaluated using paired t-test.
Results
Synergistic effect of Ang II and glucose on superoxide anion production in MCs under chronic 
condition (Protocol 1). MCs were pre-incubated with 5.5 mM or 13.5 mM glucose, with or without the 
presence of 10−7 M of Ang II for six hours. Then, DHE was added and the intracellular Eth level was measured 
after every 10 s for up to 400 s. The chronological changes in intracellular level of Eth under such conditions are 
shown in Fig. 2. The production of Eth was significantly increased by pre-conditioning with 13.5 mM glucose 
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along with Ang II stimulation, compared to that in control (slope: 4.24 ± 0.42 units/s; p < 0.05, compared to 
control); however, it was not increased after pre-conditioning with 5.5 mM glucose even with Ang II stimulation 
(slope: 3.57 ± 0.13 units/s; p > 0.05, not significant, compared to control). There was no increase in intracellular 
ROS level after pre-treatment with AT1R antagonist (RNH6720) and it was comparable with the ROS level in 
control (slope: 2.61 ± 0.16 units/s; p < 0.05, compared to Ang II stimulated samples).
Although not shown in Fig. 2, a scavenger agent of superoxide anions, Tiron (10 µM), ameliorated the Eth 
responses obtained after pre-treatment with 13.5 mM glucose along with Ang II stimulation, which confirmed 
that stimulation with high glucose along with Ang II increased the production of O.2− in MCs (slope: 1.04 ± 0.45 
units/s; p < 0.05, compared to samples treated with Ang II without Tiron condition). Furthermore, to exclude the 
effect of osmolarity due to high glucose, the substitution of buffer with 13.5 mM L-glucose did not enhance the 
Ang II-induced O.2− production (slope: 0.93 ± 0.21 units/s; p < 0.05, compared to samples treated with Ang II 
along with 13.5 mM D-glucose).
Effect of Ang II on ROS production in MCs (Protocol 2). Effect of Ang II on the production of ROS 
was assessed in MCs. MCs were pre-incubated in the medium containing 13.5 mM glucose for 6 hours. After the 
Figure 1. Fluorescence intensity of ethidium derived due to the oxidation of DHE by intracellular superoxide 
(Protocol 1). The fluorescence intensity reflects the levels of intracellular superoxide. The dihydroethidium 
(DHE) administered in the buffer penetrates cell membrane and is oxidized by superoxide anions to form 
ethidium (Eth), which emits red fluorescence (excitation filter: 480 nm wavelength; emission filter: 605 nm 
wavelength). All living cells, which were attached to the bottom of cover glass, were examined for the 
fluorescence emission after every 10 s. We estimated that the intracellular superoxide level was the highest after 
pre-conditioning with 13.5 mM glucose + Ang II. Abbreviations: Ang II, angiotensin II; DHE, dihydroethidium; 
Glu, glucose; mM, mmoL/L; RNH, angiotensin II type 1 receptor antagonist; s, seconds.
Figure 2. Chronological changes in levels of intracellular ethidium under different pre-conditionings (Protocol 1). 
The slope of intracellular ethidium signal from each living mesangial cell reflects the level of intracellular 
superoxide after each pre-conditioning (above: 5.5 mM glucose; below: 13.5 mM glucose). Ethidium signal was 
measured every 10 s after administering DHE. The signal slopes were significantly different in the presence of 
Ang II stimulation after pre-conditioning with 13.5 mM glucose, but were not different after pre-conditioning 
with 5.5 mM glucose. The error bar of each plot shows standard error of the measured ethidium signal. 
Abbreviations: Ang II, angiotensin II; DHE, dihydroethidium; n.s., not significant; RNH, angiotensin II type 1 
receptor antagonist.
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pre-incubation, ROS produced in the MCs were quantified using CM-H2DCFDA. O.2−, a primary compound 
of ROS, rapidly catalyzes into hydrogen peroxide (H2O2) or reacts with NO to form peroxynitrite (ONOO−). 
H2DCF reacts rapidly with both H2O2 and ONOO−, and thus, reflects the total amount of O.2−, indirectly. As 
shown in Fig. 3, the vehicle buffer containing inactivated CM-H2DCFDA without Ang II did not increase the 
levels of activated DCF. However, once 10−7 M Ang II was added to the experimental buffer, the intracellular ROS 
level was significantly and rapidly increased (slope for 0–150 and 200–350 s: 0.38 ± 0.10 vs. 1.11 ± 0 .06, p < 0.05). 
Pre-treatment with 50 mU/L of PEG-catalase, which reduces oxidative stress, significantly reduced the slope 
(0.50 ± 0.08 units/s), compared to that in samples treated with 13.5 mM glucose without PEG-catalase (p < 0.05). 
These results suggested that the production of the intracellular ROS started immediately (within less than 100 s) 
after the exposure of MCs to Ang II stimulation.
Effect of glucose concentration on the production of Ang II-induced H2o2 (Protocol 2). We 
also compared the levels of Ang II-induced ROS production under various glucose levels (i.e. 5.5 mM, 13.5 mM, 
and 27.8 mM). MCs were pre-incubated in the medium containing various concentrations of glucose for 6 h. 
After the pre-incubation, the media were replaced with vehicle buffer. Then the vehicle was exchanged with the 
experimental buffer containing 10−7 M Ang II. If ROS is produced in the MCs, fluorescent signals of activated 
DCF get enhanced. As shown in Fig. 3, the vehicle buffer containing inactivated CM-H2DCFDA, without Ang II, 
did not increase the levels of activated DCF in samples pre-conditioned with any of the glucose concentrations 
(slopes: 0.28 ± 0.06, 0.38 ± 0.10, and 0.31 ± 0.06 units/s for 5.5 mM, 13.5 mM and 27.8 mM glucose, respectively). 
Interestingly, once 10−7 M Ang II was added to the experimental buffer, the intracellular ROS was significantly 
increased under every glucose concentration (slopes: 0.90 ± 0.13, 1.11 ± 0.06, and 1.70 ± 0.28 units/s for 5.5 mM, 
13.5 mM, and 27.8 mM glucose, respectively). These data suggested that the level of Ang II-induced mesangial 
oxidative stress after Ang II exposure was dependent on the glucose level during pre-conditioning.
Effect of two types of angiotensin II receptors on oxidative stress. While the pre-treatment with 
RNH-6270 significantly suppressed the AT1R-induced oxidative stress in mesangial cells (slope: 0.53 ± 0.10 
units/s; p < 0.05, compared to vehicle), pre-treatment with 10 µM PD123319 (PD), an AT2R-specific blocker, sig-
nificantly enhanced oxidative stress (slope: 1.58 ± 0.22 units/s; p < 0.05, compared to vehicle), as shown in Fig. 4. 
These results show that ROS production is regulated by the balance of AT1R and AT2R.
Discussion
In this study, we showed that Ang II-mediated induction of oxidative stress in mesangial cells is dependent to the 
extracellular glucose level around the MCs. Moreover, we demonstrated that pre-conditioning with high glucose 
caused rapid generation of mesangial oxidative stress within several minutes of Ang II-stimulation. Such Ang 
II-induced generation of oxidative stress under high glucose condition resulted from AT1R effect, since AT1R 
inhibitor apparently restored the ROS level to a normal range.
Ang II exposure has already been known to cause mesangial cell damage or apoptosis19. As discussed earlier, 
MCs are not merely supporting tissues which sustain glomerular structure, but they can also contract capillaries 
or function as phagocytes. Mesangial damage has been known to lead to many glomerular diseases, including 
diabetic nephropathy20,21. However, the exact physiological mechanism of mesangial damage in diabetic nephrop-
athy is not yet known, even though diabetic nephropathy is the leading cause of end-stage renal disease22. This 
study demonstrated a potential mechanism (i.e. ROS production in MCs) behind the development of diabetic 
nephropathy under mildly-elevated serum glucose levels, which is further augmented by Ang II stimulation. 
This theory is supported by a previous study which showed that co-administration of high levels of glucose and 
Figure 3. Chronological changes in levels of intracellular activated CM-H2DCFDA before and after angiotensin 
II stimulation (Protocol 2). In this protocol, acute response of H2O2 level against angiotensin II stimulation 
in mesangial cells was evaluated. The vehicle buffer containing only inactivated CM-H2DCFDA without 
angiotensin II did not increase the activated CM-H2DCFDA levels in any of the samples pre-conditioned with 
glucose. Once 10−7 M angiotensin II was added to the experimental buffer, intracellular superoxide level was 
rapidly enhanced within several minutes after changing the buffer at every glucose level, especially under high 
glucose levels (13.5 mM and 27.8 mM). The error bar of each plot shows standard error. Abbreviations: Ang II, 
angiotensin II; Glu, glucose; mM, mmoL/L; PEG-Cat; polyethylene glycol catalase; s, second.
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Ang II stimulation under chronic condition activated MC inflammation via toll-like receptor 4 signaling23. In 
addition to the findings of this previous report, our data demonstrated that oxidative stress was induced in MCs 
shortly after the stimulation of Ang II. In addition, our data indicated that if such Ang II stimulation persisted for 
more than several hours, MC oxidative stress could be induced even under the condition of only mildly elevated 
glucose levels.
Based on these findings that glucose and Ang II stimulation may play synergistic effect on ROS produc-
tion, an important therapeutic strategy for diabetic nephropathy has been suggested wherein it would 
be necessary to maintain the serum glucose level within a normal range. In addition, suppressing the 
renin-angiotensin-aldosterone axis by Ang II receptor blockers (ARBs) would be effective in preventing the pro-
gression of mesangial damage. More specifically, based on the result shown in Fig. 4, AT1R-receptor blockers, 
such as olmesartan, suppressed the mesangial oxidative stress. This result corroborated with the previous studies 
that demonstrated the advantage of AT1R antagonist, such as olmesartan, losartan, or irbesartan in therapeutic 
management of the hypertensive patients with type-2 diabetes24–27. Considered together with our findings, AT1R 
antagonists would be beneficial both for controlling hypertension by blocking AT1R-mediated vessel contrac-
tion and for preventing end-stage renal disease by suppressing the AT1R-mediated mesangial oxidative stress. In 
hypertensive patients with type-2 diabetes, administration of AT1R antagonists is highly recommended, along 
with the management of serum glucose level.
As a limitation of this study, the exact molecular pathway correlating high glucose level and mesangial Ang 
II-induced production of ROS has not been identified yet. Based on several previous reports, TLR4 and NADPH 
oxidase 4 could be among the promising candidates; however, we need to conduct additional experiments to 
validate this speculation28–31.
Conclusions
High glucose level in the surrounding extracellular fluid augmented mesangial Ang II-induced ROS production 
via AT1R leading to oxidative stress. Both glucose and Ang II exert synergistic effects on ROS production. Under 
the condition of high glucose level, Ang II stimulation rapidly activated ROS production in MCs. When MCs 
were exposed to Ang II under chronic condition for more than several hours, even mildly-elevated glucose level 
could increase the ROS production in them. In practice, not only adjusting the serum glucose level of the DM 
patients, but also suppressing the excessive activity of RAA axis could be a good strategy to prevent the mesangial 
damage in hyperglycemia-induced glomerular diseases.
Data Availability
All relevant data are provided within the paper and its supporting file (Supplementary Table 1).
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